Quince Therapeutics (QNCX) Restructuring Costs (2024 - 2026)
Quince Therapeutics (QNCX) posted quarterly Restructuring Costs of $630000.0 for Q1 2026, down 2.33% year-over-year from $645000.0 in Q1 2025, and down 5.12% quarter-over-quarter from $664000.0 in Q4 2025.
Quince Therapeutics (QNCX) Restructuring Costs (2024 - 2026) Analysis & Trends
Quince Therapeutics' Restructuring Costs history runs 3 years deep, the most recent figure standing at $630000.0 for Q1 2026.
- In Q1 2026, Restructuring Costs fell 2.33% year-over-year to $630000.0; the TTM figure through Mar 2026 stood at $2.6 million (down 19.18% YoY), while the FY2025 annual figure was $2.6 million, down 21.98% from the prior year.
- Restructuring Costs for Q1 2026 stood at $630000.0, down from $664000.0 in the prior quarter.
- The five-year high for Restructuring Costs was $970000.0 in Q2 2024, with the low at $630000.0 in Q1 2026.
- The 3-year median for Restructuring Costs is $674000.0 (2025), against an average of $731875.0.
- The sharpest annual moves came in 2025 and 2026: Restructuring Costs fell 29.48% in 2025, then fell 2.33% in 2026.
- Quince Therapeutics' Restructuring Costs stood at $774000.0 in 2024, then dropped by 14.21% to $664000.0 in 2025, then declined by 5.12% to $630000.0 in 2026.
- Business Quant data shows QNCX's Restructuring Costs at $630000.0 in Q1 2026, $664000.0 in Q4 2025, and $639000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Quince Therapeutics | 209.04 Mn | 209.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 630,000.00 |
| Dec 31, 2025 | 664,000.00 |
| Sep 30, 2025 | 639,000.00 |
| Jun 30, 2025 | 684,000.00 |
| Mar 31, 2025 | 645,000.00 |
| Dec 31, 2024 | 774,000.00 |
| Sep 30, 2024 | 849,000.00 |
| Jun 30, 2024 | 970,000.00 |